Arcturus Therapeutics Stocks List
|TBIO||F||Translate Bio, Inc.||2.19|
|TAK||D||Takeda Pharmaceutical Company Limited||1.17|
|PPH||D||Market Vectors Pharmaceutical ETF||4.5|
|IDNA||D||iShares Genomics Immunology and Healthcare ETF||3.84|
|ARKG||D||ARK Genomic Revolution Multi-Sector ETF||3.14|
|DXJ||B||WisdomTree Japan Hedged Equity Fund||2.9|
|IDOG||A||ALPS International Sector Dividend Dogs ETF||1.84|
View all Arcturus Therapeutics related ETFs...
|2021-04-09||CVAC||20 DMA Resistance||Bearish|
|2021-04-09||CVAC||Bollinger Band Squeeze||Range Contraction|
|2021-04-09||TAK||Narrow Range Bar||Range Contraction|
|2021-04-09||TAK||Lower Bollinger Band Walk||Weakness|
|2021-04-09||TBIO||Pocket Pivot||Bullish Swing Setup|
Arcturus Therapeutics is an American biotech company focused on the discovery, development and commercialization of therapeutics for rare diseases with focus on RNA. Arcturus has developed a novel, potent and safe RNA therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, gene editing, DNA, antisense, and microRNA oligotherapeutics.
The company's pipeline includes RNA therapeutics towards rare diseases such as ornithine transcarbamylase deficiency (OTCD), and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19, currently co-developed with Singaporean scientists at Duke–NUS Medical School.